DSM NV | 48,805 Euro | +0,085 +0,17 % | |
| WKN: A0JLZ7 ISIN: NL0000009827 Ticker-Symbol: DSM2 | Frankfurt | 21.05.13 | 17:27 Uhr |
Branche ChemieAktienmarkt EURONEXT-100AEX |
|
|
| Zeit | Aktuelle Nachrichten
Sprache: | Leser | Medien | |
|---|---|---|---|---|
| 17.05. | DSM Agro Produc standalone Mar '13 sales at Rs 3.62 crore | 1 | moneycontrol.com | |
| 14.05. | DSM – Wie groß ist die Kraft der Bullen? | 11 | GodmodeTrader.de | |
| 07.05. | DSM N.V.: DSM to acquire 19% interest in Andre Pectin (China) | 48 | Thomson Reuters ONE | |
| Royal DSM, the global Life Sciences and Materials Sciences company, announces today that it has signed agreements to acquire a 19% equity interest in Yantai Andre Pectin Co. Ltd. (Andre... Mehr lesen zu: DSM N.V.: DSM to acquire 19% interest in Andre Pectin (China) | ||||
| 06.05. | XFRA CAPITAL ADJUSTMENT INFORMATION - 07.05.2013 - 1 | 96 | Xetra Newsboard | |
| FOLGENDE WERTPAPIERE WERDEN AM 06.05.2013 CUM KAPITALMASSNAHME UND AM
07.05.2013 EX KAPITALMASSNAHME GEHANDELT.
THE FOLLOWING SHARES ARE TRADED CUM CAPITAL ADJUSTMENT ON 06.05.2013
AND EX CAPITAL... Mehr lesen zu: XFRA CAPITAL ADJUSTMENT INFORMATION - 07.05.2013 - 1 | ||||
| 06.05. | XETI CAPITAL ADJUSTMENT INFORMATION - 07.05.2013 - 1 | 121 | Xetra Newsboard | |
| FOLGENDE WERTPAPIERE WERDEN AM 06.05.2013 CUM KAPITALMASSNAHME UND AM
07.05.2013 EX KAPITALMASSNAHME GEHANDELT.
THE FOLLOWING SHARES ARE TRADED CUM CAPITAL ADJUSTMENT ON 06.05.2013
AND EX CAPITAL... Mehr lesen zu: XETI CAPITAL ADJUSTMENT INFORMATION - 07.05.2013 - 1 | ||||
| 03.05. | DSM N.V.: Final dividend Royal DSM | 88 | Thomson Reuters ONE | |
| The DSM Annual General Meeting of Shareholders on 3 May 2013 passed a resolution to declare a dividend for 2012 of €1.50 per ordinary share of €1.50 par value. An interim dividend of €0.48 per ordinary... Mehr lesen zu: DSM N.V.: Final dividend Royal DSM | ||||
| 03.05. | DSM N.V.: DSM announces results of Annual General Meeting of Shareholders | 67 | Thomson Reuters ONE | |
| Royal DSM today held its Annual General Meeting of Shareholders. The following items were approved: Adoption of the Financial Statements for 2012 Adoption of the dividend for 2012 (see also... Mehr lesen zu: DSM N.V.: DSM announces results of Annual General Meeting of Shareholders | ||||
| 03.05. | DSM and Healthcare Businesswomen's Association Drive Discussion on Future Business Models in Healthcare | 58 | PR Newswire | |
| PARSIPPANY, N.J., May 3, 2013 /PRNewswire/ -- DSM and the Metro Chapter of the Healthcare Businesswomen's Association (HBA) will host an expert panel examining the global and domestic market forces... Mehr lesen zu: DSM and Healthcare Businesswomen's Association Drive Discussion on Future Business Models in Healthcare | ||||
| 02.05. | Royal DSM's Management Discusses Q1 2013 Results - Earnings Call Transcript | 3 | Seeking Alpha | |
| 02.05. | DSM reports sales increase, profits decrease | 5 | Xinhuanet | |
| 02.05. | DSM N.V.: DSM reports good start to the year in challenging environment | 106 | Thomson Reuters ONE | |
| DSM records higher Q1 EBITDA of €311 million (Q1 2012: €306 million) Healthy profitability in Life Sciences with Nutrition proving resilience Materials Sciences delivered a solid performance... Mehr lesen zu: DSM N.V.: DSM reports good start to the year in challenging environment | ||||
| 30.04. | Royal DSM opens plant to make anti-reflective coating | 5 | Renewable Energy Focus | |
| 26.04. | DSM: Caprolactam-Anlage in Geleen abgestellt | 28 | KunststoffWeb | |
| 23.04. | DSM, DecImmune collaborate to develop N2 pathway blocking antibody | 2 | Pharma Bus Review | |
| 23.04. | DSM Pharmaceutical to open new Australian cGMP biopharmaceutical facility in June | - | Pharma Bus Review | |
| 22.04. | DSM announces June opening of new cGMP biopharmaceutical manufacturing operation in Brisbane, Australia | 27 | PR Newswire | |
| PARSIPPANY, N.J., April 22, 2013 /PRNewswire/ -- The DSM facility was built with cooperation from the Queensland and Commonwealth Governments of Australia. Karen King, President of DSM Biologics,... Mehr lesen zu: DSM announces June opening of new cGMP biopharmaceutical manufacturing operation in Brisbane, Australia | ||||
| 22.04. | DSM and DecImmune Therapeutics Sign Agreement to Develop N2 Pathway Blocking Antibody | 18 | PR Newswire | |
| PARSIPPANY, N.J., April 22, 2013 /PRNewswire/ --DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM (NYSE, Euronext: DSM KON), announced today that it has signed... Mehr lesen zu: DSM and DecImmune Therapeutics Sign Agreement to Develop N2 Pathway Blocking Antibody | ||||
| 19.04. | DSM – Kommt jetzt ein starkes Kaufsignal? | 12 | GodmodeTrader.de | |
| 17.04. | Barclays belässt DSM auf 'Overweight' - Ziel 70 Euro | 138 | APA-dpa-AFX-Analyser | |
| Die britische Investmentbank Barclays
hat die Einstufung für DSM vor der anstehenden Berichtssaison in der
europäischen Chemiebranche auf "Overweight" mit einem Kursziel von
70 Euro belassen.... Mehr lesen zu: Barclays belässt DSM auf 'Overweight' - Ziel 70 Euro | ||||
| 17.04. | Nomura belässt DSM auf 'Buy' - Ziel 64 Euro | 120 | APA-dpa-AFX-Analyser | |
| Das Analysehaus Nomura hat die
Einstufung für DSM auf "Buy" mit einem Kursziel von 64 Euro
belassen. In Erwartung schwächerer Zahlen für das erste Quartal als
bislang prognostiziert habe er seine... Mehr lesen zu: Nomura belässt DSM auf 'Buy' - Ziel 64 Euro | ||||
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| BASF | 75,35 | +1,91 % | BASF: Die Deutsche Bank würde einsteigen |
| BAYER | 84,65 | +0,63 % | DAX schafft erneut die Wende: Bayer, Commerzbank, Continental, Deutsche Bank, Lufthansa, Telekom, E.on, Kontron, Metro und United Internet im Fokus |
| LANXESS | 58,07 | +1,18 % | Lanxess: Reifennachfrage beflügelt Aktienkurs |
| K+S | 32,90 | +0,55 % | K+S: Dividendenabschlag als Kaufchance? |
| WACKER CHEMIE | 56,22 | +9,00 % | PRESSESPIEGEL/Unternehmen: COMMERZBANK, DEUTSCHE POST, WACKER CHEMIE, NÜRBURGRING, DZ BANK |
